Author

Wan‐Yu Chu

Observed name: Wan-Yu Chu

Institutions: Uppsala University, The Netherlands Cancer Institute

Observed institutions: Uppsala University, Utrecht University, The Netherlands Cancer Institute, University Medical Center Utrecht

ORCID: 0000-0002-0402-8807

Observed ORCID: 0000-0002-0402-8807

OpenAlex ID: A5067403279

Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial

2024 · Ahmed H Fahal, Eiman Siddig Ahmed, et al. · The Lancet Infectious Diseases · 40

Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study

2023 · Brima Musa Younis, Ahmed Mudawi Musa, et al. · PLoS neglected tropical diseases · 40

PDF

Pyronaridine: a review of its clinical pharmacology in the treatment of malaria

2023 · Wan-Yu Chu, Thomas P C Dorlo · Journal of Antimicrobial Chemotherapy · 28

PDF

Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates

2021 · Wan-Yu Chu, Kim V. Annink, et al. · Clinical Pharmacokinetics · 19

PDF

A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children

2022 · A. Laura Nijstad, Wan-Yu Chu, et al. · Pharmaceutical Research · 14

PDF

Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates

2022 · Wan-Yu Chu, Karel Allegaert, et al. · Clinical Pharmacokinetics · 10

PDF

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis

2023 · Luka Verrest, Ignace C Roseboom, et al. · Journal of Antimicrobial Chemotherapy · 9

PDF

Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa

2024 · Wan-Yu Chu, Luka Verrest, et al. · The Journal of Infectious Diseases · 8

PDF

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia

2024 · Semra Palić, Wan-Yu Chu, et al. · Journal of Antimicrobial Chemotherapy · 8

Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model

2024 · Luka Verrest, Séverine Monnerat, et al. · PLoS neglected tropical diseases · 5

PDF

Importance of Lysosomal Trapping and Plasmodium Parasite Infection on the Pharmacokinetics of Pyronaridine: A Physiologically Based Pharmacokinetic Model-Based Study

2025 · Wan-Yu Chu, Wietse M. Schouten, et al. · Clinical Pharmacokinetics · 4

PDF

Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole, and Hydroxyitraconazole in Sudanese Patients With Eumycetoma

2025 · Wan-Yu Chu, Ahmed H Fahal, et al. · The Journal of Infectious Diseases · 3

PDF

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post‐Kala‐Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing

2025 · Wan‐Yu Chu, Om Prakash Singh, et al. · Clinical Pharmacology & Therapeutics · 2

PDF

Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia—authors’ response

2025 · Thomas P C Dorlo, Wan-Yu Chu · Journal of Antimicrobial Chemotherapy · 2

Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis

2026 · Wan-Yu Chu, Om Prakash Singh, et al. · International Journal of Antimicrobial Agents · 1

Population Pharmacokinetics and Target Attainment of Allopurinol and Oxypurinol Before, During, and After Cardiac Surgery with Cardiopulmonary Bypass in Neonates with Critical Congenital Heart Disease

2024 · Wan-Yu Chu, Maaike Nijman, et al. · Clinical Pharmacokinetics · 1

PDF

Female contraceptive cover duration for miltefosine-containing regimens for the treatment of women with leishmaniasis

2026 · Wan-Yu Chu, Fabiana Alves, et al. · medRxiv

PDF

Advancing Drug Therapy in Poverty-Related Diseases

2025 · Wan-Yu Chu · Utrecht University Repository (Utrecht University)

Comment on “Dosing implications for liposomal amphotericin B in pregnancy”

2023 · Wan‐Yu Chu, Thomas P. C. Dorlo · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

PDF

Works count: 19

Citation count: 194

H-index: 8

I10-index: 6